|Application:||Gene expression microarray analysis|
|Number of samples:||10|
|Release date:||Jun 23 2016|
|Last update date:||Aug 23 2018|
|Diseases:||Leukemia, Murine Acquired Immunodeficiency Syndrome, Hematologic Neoplasms|
|Dataset link||Expression profiling of murine leukemia stem cell (LSC) lines established ex vivo by coexpression of R882H-mutated DNMT3A and NRAS-G12D post treatment with Dot1l inhibitor (Microarray)|
Gene expression data were generated using Mouse Genome 430 2.0 Microarray (Affymetrix) for four independently derived RH-RAS LSC lines (termed as LSC RH-RAS #1, #2, #3 and #4), two RH-RAS LSC lines (LSC RH-RAS #1 and # 3) treated with 1 µM SGC0946 (a Dot1l-specific small-molecule inhibitor) for 4 days, one MLL-AF9-transformed progenitor line and three NUP98-JARID1A transformed progenitor lines.